Antiplatelet and antithrombotic effect of F 16618, a new thrombin proteinase-activated receptor-1 (PAR1) antagonist.

about

Targeting PAR1: Now What?Human endoglin as a potential new partner involved in platelet-endothelium interactions.

P2860

Q39338913-1B2E9EDF-28EB-4C36-BE48-F7FD68DB4A70 Q48109054-BFE657A0-7611-4A4D-9AC6-67BB7CA1AB8F

P2860

Antiplatelet and antithrombotic effect of F 16618, a new thrombin proteinase-activated receptor-1 (PAR1) antagonist.

Item

http://www.wikidata.org/entity/Q42198115

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Antiplatelet and antithromboti ...... receptor-1 (PAR1) antagonist.

@en

Antiplatelet and antithromboti ...... receptor-1 (PAR1) antagonist.

@nl

type

Item

label

Antiplatelet and antithromboti ...... receptor-1 (PAR1) antagonist.

@en

Antiplatelet and antithromboti ...... receptor-1 (PAR1) antagonist.

@nl

prefLabel

Antiplatelet and antithromboti ...... receptor-1 (PAR1) antagonist.

@en

Antiplatelet and antithromboti ...... receptor-1 (PAR1) antagonist.

@nl

P1476

Antiplatelet and antithromboti ...... receptor-1 (PAR1) antagonist.

@en

P2093

B Le Grand

http://www.w3.org/2001/XMLSchema#string

C Bachelot-Loza

http://www.w3.org/2001/XMLSchema#string

F Grelac

http://www.w3.org/2001/XMLSchema#string

F Nadal-Wollbold

http://www.w3.org/2001/XMLSchema#string

M Dumas

http://www.w3.org/2001/XMLSchema#string

M Perez

http://www.w3.org/2001/XMLSchema#string

P Gaussem

http://www.w3.org/2001/XMLSchema#string

R Létienne

http://www.w3.org/2001/XMLSchema#string

T Bourbon

http://www.w3.org/2001/XMLSchema#string

T Mirault

http://www.w3.org/2001/XMLSchema#string

P2860

Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity

Mechanisms of action of proteinase-activated receptor agonists on human platelets

A dual thrombin receptor system for platelet activation

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis.

Guide to Receptors and Channels (GRAC), 5th edition.

The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3-kinase pathway in maintaining thrombin-induced platelet aggregation

Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity.

Role of protease-activated receptors in the vascular system.

RWJ-58259: a selective antagonist of protease activated receptor-1.

P304

1827-1835

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5381.2011.01668.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

165

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51633916

http://www.w3.org/2001/XMLSchema#string

P698

21913899

http://www.w3.org/2001/XMLSchema#string

P932

3372833

http://www.w3.org/2001/XMLSchema#string

Antiplatelet and antithrombotic effect of F 16618, a new thrombin proteinase-activated receptor-1 (PAR1) antagonist.

about

P2860

P2860

Antiplatelet and antithrombotic effect of F 16618, a new thrombin proteinase-activated receptor-1 (PAR1) antagonist.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932